HIV Surveillance Data Tables
COVID-19 has affected nearly every facet of our daily lives. The pandemic has also disrupted HIV testing services and clinic attendance making the interpretation of surveillance data more complex in 2020. For these reasons, provisional HIV surveillance data tables will not be released this month. The HIV data tables will be issued in May 2022, when the full reports that provide commentary and contextual information will be published (2020 HIV Surveillance Report and HIV Surveillance Supplemental Report: Monitoring HIV Prevention and Care Outcomes Using Surveillance Data, 2020). Because of the disruptions in testing and clinical services, some derived estimates based on these data (e.g., incidence, knowledge of status) will not be possible for 2020.
HIV Surveillance Data Tables are based on data from CDC’s National HIV Surveillance System. The Data Tables format allows for expedited release of surveillance data, improving its timeliness and utility to better equip HIV prevention programs with tools to help identify and address gaps in HIV prevention and facilitate resource allocation.
- Vol. 2 No. 5. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through September 2021; and Preexposure Prophylaxis (PrEP) Data Reported through June 2021
- Vol. 2 No. 4. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2021; and Preexposure Prophylaxis (PrEP) Data Reported through March 2021
- Vol. 2 No. 3. Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): National HIV Surveillance System data reported through March 2021; and preexposure prophylaxis (PrEP) data reported through December 2020. HIV Surveillance Data Tables 2021;2(No. 3)
- Vol. 2 No. 2. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Early Release): National HIV Surveillance System Data Reported through December 2020; and Preexposure Prophylaxis (PrEP) Data Reported through September 2020
- Vol. 2 No. 1. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data) : HIV Diagnoses and Linkage to HIV Medical Care, 2019 and 2020 (Reported through September 2020); and Preexposure Prophylaxis (PrEP), 2018 (Updated), 2019 and 2020 (Reported through June 2020)
- Vol. 1 No. 6. Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): HIV Diagnoses and Linkage to HIV Medical Care, 2019 and 2020 (Reported through June 2020)
- Vol. 1 No. 5. Diagnoses of HIV Infection Among Adults Aged 50 Years and Older—United States and 6 Dependent Areas 2014–2018
- Vol. 1 No. 4. Diagnoses of HIV Infection among Adolescents and Young Adults United States and 6 Dependent Areas, 2018
- Vol. 1. No. 3: Diagnoses of HIV Infection among Adults and Adolescents in Metropolitan Statistical Areas United States and Puerto Rico, 2018
- Vol. 1. No. 2: Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): HIV Diagnoses and Linkage to HIV Medical Care, 2019 (Reported through December 2019); and Preexposure Prophylaxis (PrEP)—2018, Updated
- Vol. 1 No. 1: Core Indicators for Monitoring the Ending the HIV Epidemic Data Tables pdf icon[PDF – 1 MB]